Artal Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,779,708
| Closed | -$3.35M | – | 105 |
|
|
2017
Q4 | $3.35M | Buy |
1,779,708
+314,325
| +21% | +$591K | 0.05% | 46 |
|
|
2017
Q3 | $3.64M | Hold |
1,465,383
| – | – | 0.06% | 46 |
|
|
2017
Q2 | $4.04M | Hold |
1,465,383
| – | – | 0.07% | 48 |
|
|
2017
Q1 | $4.42M | Hold |
1,465,383
| – | – | 0.1% | 44 |
|
|
2016
Q4 | $4.63M | Hold |
1,465,383
| – | – | 0.1% | 28 |
|
|
2016
Q3 | $5M | Hold |
1,465,383
| – | – | 0.1% | 34 |
|
|
2016
Q2 | $3.35M | Hold |
1,465,383
| – | – | 0.07% | 37 |
|
|
2016
Q1 | $3.68M | Sell |
1,465,383
-123,092
| -8% | -$309K | 0.07% | 30 |
|
|
2015
Q4 | $5.26M | Hold |
1,588,475
| – | – | 0.1% | 33 |
|
|
2015
Q3 | $3.85M | Hold |
1,588,475
| – | – | 0.09% | 27 |
|
|
2015
Q2 | $4.65M | Hold |
1,588,475
| – | – | 0.2% | 32 |
|
|
2015
Q1 | $6.37M | Hold |
1,588,475
| – | – | 0.29% | 34 |
|
|
2014
Q4 | $4.78M | Buy |
+1,588,475
| New | +$4.78M | 0.17% | 33 |
|